Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Anna Estival-Gonzalez"'
Autor:
Sara Senti Farraraons, Anna Estival Gonzalez, Cuadrado Velazquez, Clara Gene Skrabec, Ignasi Camps Ausas
Publikováno v:
Iranian Journal of Colorectal Research, Vol 7, Iss 4, Pp 1-4 (2019)
Desmoid tumor, also called aggressive fibromatosis, is a rare fibroblastic proliferation of connective tissue and skeletal muscle aponeurosis. The aetiology of desmoid tumours is poorly understood, but they have been related with oestrogen stimuli, p
Externí odkaz:
https://doaj.org/article/2b2223cbbde94231a04aeeab7034bcdc
Autor:
Mrinal M. Gounder, Albiruni Abdul Razak, Neeta Somaiah, Sant Chawla, Javier Martin-Broto, Giovanni Grignani, Scott M. Schuetze, Bruno Vincenzi, Andrew J. Wagner, Bartosz Chmielowski, Robin L. Jones, Richard F. Riedel, Silvia Stacchiotti, Elizabeth T. Loggers, Kristen N. Ganjoo, Axel Le Cesne, Antoine Italiano, Xavier Garcia del Muro, Melissa Burgess, Sophie Piperno-Neumann, Christopher Ryan, Mary F. Mulcahy, Charles Forscher, Nicolas Penel, Scott Okuno, Anthony Elias, Lee Hartner, Tony Philip, Thierry Alcindor, Bernd Kasper, Peter Reichardt, Lore Lapeire, Jean-Yves Blay, Christine Chevreau, Claudia Maria Valverde Morales, Gary K. Schwartz, James L. Chen, Hari Deshpande, Elizabeth J. Davis, Garth Nicholas, Stefan Gröschel, Helen Hatcher, Florence Duffaud, Antonio Casado Herráez, Roberto Diaz Beveridge, Giuseppe Badalamenti, Mikael Eriksson, Christian Meyer, Margaret von Mehren, Brian A. Van Tine, Katharina Götze, Filomena Mazzeo, Alexander Yakobson, Aviad Zick, Alexander Lee, Anna Estival Gonzalez, Andrea Napolitano, Mark A. Dickson, Dayana Michel, Changting Meng, Lingling Li, Jianjun Liu, Osnat Ben-Shahar, Dane R. Van Domelen, Christopher J. Walker, Hua Chang, Yosef Landesman, Jatin J. Shah, Sharon Shacham, Michael G. Kauffman, Steven Attia
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
JOURNAL OF CLINICAL ONCOLOGY
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Universidad de Barcelona
JOURNAL OF CLINICAL ONCOLOGY
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
PURPOSE Antitumor activity in preclinical models and a phase I study of patients with dedifferentiated liposarcoma (DD-LPS) was observed with selinexor. We evaluated the clinical benefit of selinexor in patients with previously treated DD-LPS whose s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36acf0dab8ff58803f8bced57d71ecf0
http://hdl.handle.net/2445/190172
http://hdl.handle.net/2445/190172
Autor:
Javier Martin Broto, Jeronimo Martinez Garcia, David Silva Moura, Andres Redondo, Antonio Gutierrez, Antonio Lopez-Pousa, Javier Martinez-Trufero, Isabel Sevilla, Robert Diaz Beveridge, Maria Pilar Solis-Hernandez, Amancio Carnero, Marco Perez, David Marcilla, Jose A. Lopez-Martin, Antonio Casado Herraez, Rosa Maria Alvarez Alvarez, Josefina Cruz Jurado, Anna Estival-Gonzalez, Patricio Ledesma, Nadia Hindi
Publikováno v:
Journal of Clinical Oncology. 40:11511-11511
11511 Background: CDK4/6 inhibitors showed a favorable progression-free survival (PFS) in DD LPS, a sarcoma bearing 12q 13-15 amplicon that implies CDK4 amplification. The median PFS was 4 and 7 months (m) for palbociclib and abemaciclib, respectivel
Autor:
Richard W. Tothill, Sara Fernandez, Rafael Morales, Sebastian Moran, Antonio Antón, Joan Carles, Roberto Pazo-Cid, Sergi Sayols, Maria Ruiz-Miró, Anna Martínez-Cardús, Manuel Castro de Moura, Anna Estival-Gonzalez, Catia Moutinho, Yassen Assenov, C. Balana, Josep M. Llovet, Eva Musulen, Gemma Soler, Rafael López-López, Isabel Guerra, Paolo M. Comoglio, Manel Esteller, Christoph Plass, Daniela Sia, Angel Diaz-Lagares, Holger Heyn, Federico Longo, Linda Mileshkin, David D.L. Bowtell, Xavier Matias-Guiu, Giulia Maria Stella, Josep Tabernero
Publikováno v:
Recercat. Dipósit de la Recerca de Catalunya
instname
instname
Summary Background Cancer of unknown primary ranks in the top ten cancer presentations and has an extremely poor prognosis. Identification of the primary tumour and development of a tailored site-specific therapy could improve the survival of these p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2d072c96419b819c4afcfd086adfc6f
http://hdl.handle.net/10459.1/58773
http://hdl.handle.net/10459.1/58773